Chris Pin

Chris Pin, PhD, lead author on the study, has found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Study marks first time a sex-specific genetic risk factor for pancreatic cancer has been identified

LHSC: Victoria Hospital - 

In a new study from Lawson Health Research Institute and Western University’s Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females. The study marks the first time a sex-specific genetic risk factor for pancreatic cancer has been identified.

Dr. David Hill

Dr. David Hill, scientific director at Lawson

A column by Dr. David Hill, scientific director at Lawson

The following column was provided to Hospital News by Dr. David Hill, scientific director, Lawson Health Research Institute. 

Dedicated health researchers across the country are working every day to make discoveries that improve patient outcomes and support a higher quality of life. Our research hospitals have a mandate to develop and test new treatments, technologies and procedures that address our most pressing health challenges.

Dr. Alexandra Zorzi

Dr. Alexandra Zorzi, associate scientist at Lawson Health Research Institute and paediatric hematologist/oncologist at Children’s Hospital at London Health Sciences Centre (LHSC)

Dr. Alexandra Zorzi hopes to advance childhood cancer research through collaboration and innovation.

LHSC: Children’s Hospital - 

Research on childhood cancer has been slow to progress when compared to adult cancer. While childhood cancer is less common than cancer in adults, it’s the leading cause of disease-related death in Canadian children. Meanwhile three in five childhood cancer survivors go on to experience lifelong side effects.

Pages